Show simple item record

Cytomorphologic features of metastatic urothelial carcinoma in serous effusions

dc.contributor.authorCheng Huang, Chengen_US
dc.contributor.authorAttele, Anojaen_US
dc.contributor.authorMichael, Claire W.en_US
dc.date.accessioned2013-07-08T17:45:40Z
dc.date.available2014-09-02T14:12:53Zen_US
dc.date.issued2013-07en_US
dc.identifier.citationCheng Huang, Cheng; Attele, Anoja; Michael, Claire W. (2013). "Cytomorphologic features of metastatic urothelial carcinoma in serous effusions." Diagnostic Cytopathology 41(7): 569-574. <http://hdl.handle.net/2027.42/98804>en_US
dc.identifier.issn8755-1039en_US
dc.identifier.issn1097-0339en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/98804
dc.description.abstractMetastatic urothelial carcinoma (UC) to serous effusion (SE) is extremely rare and its cytomorphological features have only been described in case reports. In this study, we searched the pathology database at University of Michigan for SEs due to metastatic UC in the last 20 years. A total of 25 cases from 20 patients with clinically and pathologically confirmed metastatic UC in SEs were retrieved. The specimens consisted of 15 pleural, 8 peritoneal, and 2 pericardial effusions. Smears were reviewed and evaluated for the following features: cellularity, single cells, cell clusters or short cords, cell wrapping, “windows” between the cells, two‐tone cytoplasm, cytoplasmic vacuoles, signet ring cells, nuclear to cytoplasmic (N/C) ratio, nuclear hyperchromasia, irregular nuclear membrane, nuclear centricity, double or multiple nuclei, nucleoli, anaplastic cells and mitosis. Our results showed that UC manifested in SEs predominantly as a single cell population with or without clusters or short cords, and frequently exhibited the “cell wrapping” of two or more cells. Individual UC cell in SEs exhibited nuclear enlargement with increased N/C ratio, irregular nuclear membranes, hyperchromatic coarse chromatin and frequently prominent nucleoli. Double or multinucleated cells, cells with vacuolated cytoplasm or signet ring appearance were also frequently present. Our results demonstrated that while certain features could suggest the diagnosis of UC, the cytomorphological features are not specific and often overlap with those of reactive mesothelium, mesothelioma, metastatic adenocarcinoma, or squamous cell carcinoma in SEs. Accurate diagnosis of UC rests on the combination of clinical history, cytomorphologic features and appropriate immunohistochemical panel. Diagn. Cytopathol. 2013. © 2012 Wiley Periodicals, Inc.en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherUrothelial Carcinomaen_US
dc.subject.otherDifferential Diagnosisen_US
dc.subject.otherCytopathologyen_US
dc.subject.otherSerous Effusionsen_US
dc.titleCytomorphologic features of metastatic urothelial carcinoma in serous effusionsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPathologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan, 1500 E. Medical Center Dr, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDepartment of Pathology, Case Western Reserve University/University Hospitals Case Medical Center, 11100 Euclid Ave, Room 212B, Cleveland OH 44106, USAen_US
dc.contributor.affiliationotherDepartment of Pathology, Case Western Reserve University/University Hospitals Case Medical Center, 11100 Euclid Ave, Room 212B, Cleveland OH 44106, USAen_US
dc.identifier.pmid22833290en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/98804/1/22896_ftp.pdf
dc.identifier.doi10.1002/dc.22896en_US
dc.identifier.sourceDiagnostic Cytopathologyen_US
dc.identifier.citedreferenceMicheal CW. Maligant mesothelioma. In: Davidson B, Pinar F, Michael CW, editors. Serous effusions. London: Springer; 2012. p 79 – 98.en_US
dc.identifier.citedreferenceJemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277 – 300.en_US
dc.identifier.citedreferenceAl‐Sukhun S, Hussain M. Current understanding of the biology of advanced bladder cancer. Cancer 2003; 97 ( 8 Suppl ): 2064 – 2075.en_US
dc.identifier.citedreferenceBabaian RJ, Johnson DE, Llamas L, Ayala AG. Metastases from transitional cell carcinoma of urinary bladder. Urology 1980; 16: 142 – 144.en_US
dc.identifier.citedreferenceSengelov L, Kamby C, von der Maase H. Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. J Urol 1996; 155: 111 – 114.en_US
dc.identifier.citedreferencePark S, Hong B, Kim CS, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. JUrol 2004; 171 ( 2, Part 1 ): 621 – 625.en_US
dc.identifier.citedreferenceShinagare AB, Fennessy FM, Ramaiya NH, Jagannathan JP, Taplin ME, Van den Abbeele AD. Urothelial cancers of the upper urinary tract: Metastatic pattern and its correlation with tumor histopathology and location. J Comput Assist Tomogr 2011; 35: 217 – 222.en_US
dc.identifier.citedreferenceFabozzi SJ, Newton JR, Jr, Moriarty RP, Schellhammer PF. Malignant pericardial effusion as initial solitary site of metastasis from transitional cell carcinoma of the bladder. Urology 1995; 45: 320 – 322.en_US
dc.identifier.citedreferenceMcGrath SM, Rana DN, Lynch M, Desai M. Metastatic transitional cell carcinoma causing a unilateral pleural effusion: A case report. Acta Cytol 2008; 52: 351 – 353.en_US
dc.identifier.citedreferenceXiao GQ. Cytomorphology of urothelial carcinomatous peritoneal effusion. Cytopathology 2008; 19: 131 – 133.en_US
dc.identifier.citedreferenceCimino‐Mathews A, Ali SZ. Metastatic urothelial carcinoma with signet ring features: Cytomorphologic findings in abdominal paracentesis. Diagn Cytopathol 2011; 39: 132 – 134.en_US
dc.identifier.citedreferenceKho‐Duffin J, Tao LC, Cramer H, Catellier MJ, Irons D, Ng P. Cytologic diagnosis of malignant mesothelioma, with particular emphasis on the epithelial noncohesive cell type. Diagn Cytopathol 1999; 20: 57 – 62.en_US
dc.identifier.citedreferenceHiggins JP, Kaygusuz G, Wang L, et al. Placental S100 (S100P) and GATA3: Markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 2007; 31: 673 – 680.en_US
dc.identifier.citedreferenceHida CA, Gupta PK. Cercariform cells: Are they specific for transitional cell carcinoma? Cancer 1999; 87: 69 – 74.en_US
dc.identifier.citedreferenceCakir E, Demirag F, Aydin M, Unsal E. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis. Diagn Cytopathol 2009; 37: 4 – 10.en_US
dc.identifier.citedreferenceEhya H. The cytologic diagnosis of mesothelioma. Semin Diagn Pathol 1986; 3: 196 – 203.en_US
dc.identifier.citedreferenceStevens MW, Leong AS, Fazzalari NL, Dowling KD, Henderson DW. Cytopathology of malignant mesothelioma: A stepwise logistic regression analysis. Diagn Cytopathol 1992; 8: 333 – 341.en_US
dc.identifier.citedreferenceSmith‐Purslow MJ, Kini SR, Naylor B. Cells of squamous cell carcinoma in pleural, peritoneal and pericardial fluids. Origin and morphology. Acta Cytol 1989; 33: 245 – 253.en_US
dc.identifier.citedreferenceChhieng DC, Yee H, Schaefer D, et al. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions. Cancer 2000; 90: 194 – 200.en_US
dc.identifier.citedreferenceSaad RS, Cho P, Liu YL, Silverman JF. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: A comparative study. Diagn Cytopathol 2005; 32: 156 – 159.en_US
dc.identifier.citedreferenceHasteh F, Lin GY, Weidner N, Michael CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol 2010; 118: 90 – 96.en_US
dc.identifier.citedreferencePu RT, Pang Y, Michael CW. Utility of WT‐1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions. Diagn Cytopathol 2008; 36: 20 – 25.en_US
dc.identifier.citedreferenceLi Q, Bavikatty N, Michael CW. The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion. Semin Diagn Pathol 2006; 23: 15 – 19.en_US
dc.identifier.citedreferenceYang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol 2010; 23: 654 – 661.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.